Jul-30-18
The StatStrip fingerstick glucometer from Nova Biomedical is the first of its kind to receive FDA approval for use with critically ill patients.
Typically, critically ill patients—which can also be at risk for hypoglycemia—are tested using plasma glucose, which ensures close monitoring.
The StatStrip Glucose Hospital Meter System allows caregivers to collect arterial, venous or capillary samples from all patients with the same high level of accuracy required by critically in patients. The StatStrip will resist influence from other factors and correct for abnormal hematocrit, offering trustworthy results with a less invasive process.
More Info about this Invention:
[
MEDGADGET.COM]
[
NOVABIO.US]
Add Your Comment